Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $97.2B | +$667M | 124 | 4.07% | Increased |
|
| 2 |
BlackRock
New York
| $91B | +$1.29B | 127 | 4.19% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $58.1B | -$662M | 107 | 4.86% | Reduced |
|
| 4 |
Capital Research Global Investors
Los Angeles,
California
| $32.3B | +$965M | 12 | 8.83% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $29.9B | +$3.07B | 71 | 3.44% | Increased |
|
| 6 |
Wellington Management Group
Boston,
Massachusetts
| $26.6B | +$156M | 50 | 5.92% | Increased |
|
| 7 |
Capital World Investors
Los Angeles,
California
| $17.7B | +$1.63B | 21 | 3.79% | Increased |
|
| 8 |
Bank of America
Charlotte,
North Carolina
| $17.4B | -$662M | 125 | 2.89% | Reduced |
|
| 9 |
Northern Trust
Chicago,
Illinois
| $16.8B | -$89.3M | 115 | 4.26% | Reduced |
|
| 10 |
Bank of New York Mellon
New York
| $16.2B | +$218M | 106 | 4.41% | Increased |
|
| 11 |
T. Rowe Price Associates
Baltimore,
Maryland
| $15B | -$216M | 65 | 2.29% | Reduced |
|
| 12 |
Geode Capital Management
Boston,
Massachusetts
| $14.9B | +$211M | 133 | 4.59% | Increased |
|
| 13 |
JP Morgan Chase
New York
| $14.2B | +$708M | 107 | 2.91% | Increased |
|
| 14 |
Norges Bank
Oslo,
Norway
| $12.4B | +$27.2M | 38 | 4.26% | Increased |
|
| 15 |
Primecap Management
Pasadena,
California
| $11.3B | +$143M | 15 | 8.38% | Increased |
|
| 16 |
Franklin Resources
San Mateo,
California
| $10.8B | +$273M | 35 | 5.56% | Increased |
|
| 17 |
Morgan Stanley
New York
| $10.4B | -$235M | 146 | 2.8% | Reduced |
|
| 18 |
Wells Fargo
San Francisco,
California
| $10.3B | -$686M | 124 | 3.06% | Reduced |
|
| 19 |
Dodge & Cox
San Francisco,
California
| $10.3B | -$391M | 10 | 8.24% | Reduced |
|
| 20 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $9.88B | -$755M | 122 | 4.92% | Reduced |
|
| 21 |
Goldman Sachs
New York
| $9.39B | -$1.91B | 98 | 2.54% | Reduced |
|
| 22 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $9.22B | $0 | 7 | 12.34% | Maintained |
|
| 23 |
Invesco
Atlanta,
Georgia
| $8.77B | +$347M | 66 | 2.9% | Increased |
|
| 24 |
BBA
Baker Bros. Advisors
New York
| $7.92B | +$1.18B | 36 | 59.52% | Increased |
|
| 25 |
Ameriprise
Minneapolis,
Minnesota
| $7.63B | -$55.5M | 54 | 3.38% | Reduced |
|